Mircera

Active Ingredient(s): Methoxy Polyethylene Glycol-epoetin Beta
FDA Approved: * November 14, 2007
Pharm Company: * HOFFMAN-LA ROCHE
Category: Anemia

Epoetin beta (rINN) /po.tn/ is a synthetic, recombinant[2] form of erythropoietin, a protein that promotes the production of red blood cells. It is an erythropoiesis-stimulating agent (ESA) that is used to treat anemia, commonly associated with chronic kidney failure and cancer chemotherapy. Epoetin beta is sold under the brand name NeoRecormon, among others.[3] It is on the World Health Organization's List of Essential Medicines.[4] Contents ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Mircera 50 ug/.3ml Intravenous Injection, Solution
NDC: 0004-0401
Labeler:
Genentech, Inc.
Mircera 75 ug/.3ml Intravenous Injection, Solution
NDC: 0004-0402
Labeler:
Genentech, Inc.
Mircera 100 ug/.3ml Intravenous Injection, Solution
NDC: 0004-0403
Labeler:
Genentech, Inc.
Mircera 150 ug/.3ml Intravenous Injection, Solution
NDC: 0004-0404
Labeler:
Genentech, Inc.
Mircera 200 ug/.3ml Intravenous Injection, Solution
NDC: 0004-0405
Labeler:
Genentech, Inc.
Mircera 250 ug/.3ml Intravenous Injection, Solution
NDC: 0004-0406
Labeler:
Genentech, Inc.
Mircera 30 ug/.3ml Intravenous Injection, Solution
NDC: 59353-400
Labeler:
Vifor (International) Inc.
Mircera 50 ug/.3ml Intravenous Injection, Solution
NDC: 59353-401
Labeler:
Vifor (International) Inc.
Mircera 75 ug/.3ml Intravenous Injection, Solution
NDC: 59353-402
Labeler:
Vifor (International) Inc.
Mircera 100 ug/.3ml Intravenous Injection, Solution
NDC: 59353-403
Labeler:
Vifor (International) Inc.
More Results

Related Brands

Drugs with the same active ingredients